However, SIRT2 is expressed in non–β cells and is an important tumor suppressor in some cell types (23), underscoring the need for a high degree of cell-type selectivity were SIRT2 to be therapeutically inactivated. The gene discussed is SIRT2; the disease is neoplasm.